The non-contact vital signs detector market size was valued at USD 327.36 million in 2025 and is projected to grow from USD 357.87 million in 2026 to USD 730.00 million by 2034, registering a CAGR of 9.32% during the forecast period (2026–2034). North America dominated the non-contact vital signs detector market with a market share of 39.71% in 2025.
Non-contact vital signs detectors are advanced medical devices that monitor physiological parameters such as heart rate, respiratory rate, body temperature, and blood oxygen levels without direct physical contact. These systems use technologies including radar, infrared sensors, thermal imaging, and optical monitoring to enable continuous, accurate, and hygienic patient assessment.
The non-contact vital signs detector market demand is driven by the rising adoption of remote healthcare, growing emphasis on infection prevention, and expanding elderly population. Continuous technological advancements, increasing healthcare investments, and broader use of contactless monitoring solutions are further supporting non-contact vital signs detector market growth.
Download a Free Sample To learn more about this report,
The non-contact vital signs detector market has indirect exposure to supply chain disruptions due to its reliance on semiconductor components, imaging sensors, wireless communication modules, and precision electronic parts sourced from global suppliers. Disruptions in component availability, transportation networks, and manufacturing operations have increased production costs, extended delivery timelines, and slowed the commercialization of advanced monitoring systems across healthcare facilities worldwide. The market is experiencing a capacity-constrained recovery, supported by improving semiconductor availability and steady growth in healthcare technology adoption.
Growing Adoption of AI-powered Camera Based Vital Sign Monitoring
Healthcare providers are increasingly shifting from conventional contact-based monitoring to AI-powered camera and vision based systems capable of measuring heart rate, respiratory rate, oxygen saturation, and other vital parameters without physical contact. This transition is improving infection control, enabling continuous patient observation, and supporting remote healthcare delivery across hospitals and home care settings. The integration of artificial intelligence is further enhancing measurement accuracy and real-time clinical decision-making.
Expansion of Radar-based Continuous Patient Monitoring
The market is witnessing a transition toward radar-based non-contact sensing technologies that can monitor patient vital signs through clothing and bedding without requiring cameras or wearable devices. This trend is expanding the use of continuous monitoring in intensive care units, elderly care facilities, and home healthcare while improving patient comfort and reducing caregiver workload. Companies such as Xandar Kardian offer radar-based continuous vital signs monitoring solutions for senior living communities and healthcare facilities.
The non-contact vital signs detector market forecasts continued investment activity driven by the growing adoption of AI-enabled remote patient monitoring, increasing demand for contactless healthcare technologies, and expanding digital health infrastructure. In March 2025, Dozee raised USD 8 million in a funding round to expand its AI-powered contactless remote patient monitoring platform and strengthen its presence in domestic and international healthcare markets. The investment will support the enhancement of its AI algorithms, development of advanced non-contact vital signs monitoring capabilities, expansion of manufacturing and commercial operations, and broader deployment across hospitals and healthcare facilities.
Increasing Focus on Infection Prevention and Contactless Healthcare and Advancements in Remote Photoplethysmography (rPPG) Technologies Drives Market
The growing emphasis on infection prevention is increasing the adoption of non-contact vital signs detectors across healthcare environments. Hospitals and clinics are investing in contactless monitoring technologies to reduce cross-contamination risks while maintaining continuous patient observation. This demand is encouraging manufacturers to develop advanced radar, camera, and infrared-based monitoring systems with higher clinical accuracy. As healthcare facilities prioritize safer patient care, adoption continues to expand across emergency departments, intensive care units, and long-term care settings.
Advancements in remote photoplethysmography technology are driving demand for non-contact vital signs detectors by enabling accurate measurement of heart rate, respiratory rate, and blood oxygen levels using standard cameras without physical contact. Improvements in AI algorithms and image processing have enhanced monitoring accuracy under real-world conditions. This is expanding adoption across hospitals, telemedicine, and home healthcare. For example, Philips Vital Signs Camera and Binah.ai use rPPG-based remote monitoring.
Limited Clinical Validation and Capability to Measure Comprehensive Physiological Parameters Restrain Market Expansion
Non-contact vital signs detectors require consistent clinical accuracy across different age groups, skin tones, lighting conditions, and patient movement scenarios. Variations in these factors can affect measurement reliability, making healthcare providers cautious about replacing conventional contact-based monitoring in critical care. As a result, hospitals often limit adoption to supplementary monitoring applications until broader clinical validation is established.
Most non-contact vital signs detectors accurately monitor parameters such as heart rate and respiratory rate but still have limitations in continuously measuring blood pressure, core body temperature, and other advanced physiological indicators with clinical-grade precision. This restricts their ability to replace multi-parameter bedside monitors in high-acuity settings.
Expansion of Smart Hospital Infrastructure and Increasing Adoption of Home Healthcare Offer Growth Opportunities to Market Players
The development of smart hospitals and connected care environments creates growth opportunities for non-contact vital signs detector manufacturers by enabling integration of AI-based monitoring systems with hospital information networks and digital patient platforms. Healthcare providers are increasingly adopting automated monitoring solutions to improve workflow efficiency, reduce manual observation burden, and enable real-time patient analytics. This opportunity is expected to expand as hospitals invest in intelligent wards and next-generation clinical infrastructure.
The rising demand for home-based healthcare and elderly monitoring solutions creates growth opportunities for non-contact vital signs detector providers by enabling scalable remote patient monitoring platforms. The opportunity is expected to expand as healthcare systems shift toward preventive, decentralized, and value-based care models. Market players can capitalize by developing affordable, user-friendly, and AI-enabled monitoring solutions designed for home use and integration with telehealth platforms.
High Integration Complexity and Data Privacy & Cybersecurity Concerns Challenges Market Growth
Non-contact vital signs detectors require seamless integration with electronic health records, hospital information systems, and clinical workflow platforms to deliver actionable insights. Differences in hospital IT infrastructure, interoperability standards, and cybersecurity requirements increase deployment complexity and implementation costs. This slows adoption, particularly among smaller healthcare facilities with limited digital infrastructure and technical resources.
The increasing use of camera-based and AI-driven vital signs monitoring creates concerns regarding patient data privacy, video processing security, and compliance with healthcare data regulations. These concerns can delay procurement decisions as hospitals evaluate cybersecurity risks before deploying contactless monitoring solutions.
The radar-based systems segment accounted for a share of 35.40% in 2025, owing to accurate respiratory motion detection, operation through clothing, and suitability for ICU and sleep monitoring. Its adoption increases due to privacy advantages and continuous patient observation capabilities.
The RF-based sensors segment is expected to grow at a CAGR of around 10.17% during the forecast period due to compact designs, low power consumption, and integration into smart healthcare devices. Growth is supported by increasing use in remote monitoring and connected care applications.
Request Customizationto receive a tailored report.
In 2025, hospitals accounted for a share of 54.26% due to higher adoption of continuous monitoring systems, critical care applications, and integration with digital healthcare infrastructure. Demand increases as hospitals focus on improving patient surveillance and reducing manual monitoring requirements.
The ambulatory care centers segment is expected to grow at a CAGR of 10.36% during the forecast period, driven by rising outpatient procedures, faster patient assessment needs, and compact monitoring solutions. Adoption is supported by improving workflow efficiency and decentralized healthcare delivery.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Advanced Healthcare Infrastructure and Rapid Adoption of Remote Monitoring Technologies
The North America non-contact vital signs detector market accounted for the largest regional share of 39.71% in 2025, driven by strong adoption of digital healthcare solutions, increasing deployment of remote patient monitoring systems, and advanced hospital infrastructure supporting AI-enabled monitoring technologies. The presence of leading medical technology companies and early adoption of innovative monitoring solutions further supports market expansion across hospitals, home healthcare, and elderly care settings.
The US non-contact vital signs detector market was valued at USD 112.71 million in 2025, driven by increasing integration of AI powered monitoring solutions into hospitals, intensive care units, and remote healthcare programs. The country’s strong digital health ecosystem, growing elderly population, and increasing demand for home-based healthcare solutions continue to accelerate adoption of advanced non-contact monitoring systems.
The non-contact vital signs detector market in Canada was valued at USD 17.29 million in 2025, supported by increasing investments in remote healthcare infrastructure, rising demand for elderly care monitoring, and efforts to improve healthcare accessibility across geographically dispersed regions. The expansion of telehealth services and digital healthcare initiatives creates favorable opportunities for market adoption across hospitals and community care settings.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Expansion of Digital Health Infrastructure and Rising Demand for Remote Care Solutions
The Asia Pacific non-contact vital signs detector market is expected to grow at a CAGR of 11.87% during the forecast period, showcasing the fastest regional growth. Growth is supported by increasing adoption of telemedicine platforms, expansion of AI-enabled healthcare technologies, and rising demand for scalable monitoring solutions in densely populated regions. The region’s growing elderly population, increasing chronic disease burden, and development of smart healthcare facilities are creating favorable conditions for contactless vital signs monitoring adoption.
The China non-contact vital signs detector market was valued at USD 17.09 million in 2025, driven by the deployment of smart hospital projects, integration of AI technologies into clinical workflows, and rising demand for intelligent ward monitoring systems. Government-led healthcare digitization initiatives are encouraging hospitals to adopt advanced patient monitoring solutions that improve operational efficiency and clinical decision support.
The India non-contact vital signs detector market was valued at USD 8.74 million in 2025, fueled by increasing adoption of affordable healthcare technologies, expansion of remote patient monitoring programs, and the need to address healthcare accessibility challenges across semi urban and rural regions. Healthcare providers are exploring contactless monitoring solutions to reduce dependency on continuous bedside supervision and improve patient management efficiency.
The Japan non-contact vital signs detector market was valued at USD 10.09 million in 2025, propelled by increasing deployment of sensor enabled smart homes and care facilities. The market is further driven by Japan’s focus on labor-saving healthcare technologies amid caregiver shortages, encouraging adoption of automated monitoring systems that reduce the burden on nursing staff.
The non-contact vital signs detector market competitive landscape is moderately consolidated, with competition concentrated among established healthcare technology companies, digital health providers, and specialized sensor technology developers offering AI-enabled remote monitoring solutions. Leading players compete through advancements in AI, sensor accuracy, real-time monitoring capabilities, and data analytics. Emerging companies focus on expanding clinical applications, improving affordability, and developing scalable contactless monitoring solutions. The non-contact vital signs detector market ecosystem is shaped by rising demand for remote healthcare, digital transformation of clinical workflows, regulatory advancements, and the growing need for continuous patient monitoring technologies.
March 2026: RGX Technologies' patent application for AI-enabled contactless physiological monitoring was published, advancing commercialization of remote vital-sign detection technologies.
October 2025: Covidien LP published a patent application covering a video- and infrared-based non-contact respiratory monitoring system for continuous patient monitoring.
September 2025: BRGX Technologies filed a patent for an AI-powered camera-based system capable of estimating heart rate, blood pressure, respiratory rate, and SpO₂ without physical contact.
August 2025: ResMed published a patent application for a non-contact multiparameter vital signs monitoring system using Doppler sensing to measure heart rate, respiration, and sleep-related physiological parameters.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Europe Home Infusion Therapy Market Size, Share and Forecast to 2034
Asia Pacific Home Infusion Therapy Market Size, Share & Trends | Industry Report, 2034
Asia Pacific Plasmapheresis Machines Market Size, Share and Forecast to 2034
Latin America Plasmapheresis Machines Market Size, Share by 2034
North America Powered Air Purifying Respirator Market Size & Share by 2034
North America Plasmapheresis Machines Market Size, Share, Growth, Trends Report 2034
We are featured on:
sales@straitsresearch.com